clinical trial · NCT07464119
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
Peking University First Hospital·N/A·not yet recruiting·n = 30
Diabetes MellitusiPSC-derived islet cell
brief summary
This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus.
started
Mar 16, 2026
primary completion
Dec 31, 2028
completion
Dec 31, 2033
last updated
Mar 11, 2026
official title
A Single-Arm, Open-Label Clinical Study of iPSC-Derived Islet Cells for the Treatment of Diabetes Mellitus
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol